DK0751769T3 - Medicinsk behandling under anvendelse af skjoldbruskhormoner - Google Patents
Medicinsk behandling under anvendelse af skjoldbruskhormonerInfo
- Publication number
- DK0751769T3 DK0751769T3 DK94921305T DK94921305T DK0751769T3 DK 0751769 T3 DK0751769 T3 DK 0751769T3 DK 94921305 T DK94921305 T DK 94921305T DK 94921305 T DK94921305 T DK 94921305T DK 0751769 T3 DK0751769 T3 DK 0751769T3
- Authority
- DK
- Denmark
- Prior art keywords
- medical treatment
- thyroid hormones
- treatment
- diiodothyronine
- liothyronine
- Prior art date
Links
- 239000005495 thyroid hormone Substances 0.000 title abstract 2
- 229940036555 thyroid hormone Drugs 0.000 title abstract 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 abstract 2
- ZHSOTLOTTDYIIK-ZDUSSCGKSA-N (2S)-2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C=C1 ZHSOTLOTTDYIIK-ZDUSSCGKSA-N 0.000 abstract 1
- HZCBWYNLGPIQRK-LBPRGKRZSA-N 3,3',5'-triiodo-L-thyronine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC=C1OC1=CC(I)=C(O)C(I)=C1 HZCBWYNLGPIQRK-LBPRGKRZSA-N 0.000 abstract 1
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000010496 Heart Arrest Diseases 0.000 abstract 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 229950008325 levothyroxine Drugs 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 abstract 1
- 229940035722 triiodothyronine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7980593A | 1993-06-22 | 1993-06-22 | |
| PCT/US1994/006772 WO1995000135A1 (fr) | 1993-06-22 | 1994-06-22 | Traitement medical utilisant des hormones thyroidiennes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0751769T3 true DK0751769T3 (da) | 2003-04-07 |
Family
ID=22152935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94921305T DK0751769T3 (da) | 1993-06-22 | 1994-06-22 | Medicinsk behandling under anvendelse af skjoldbruskhormoner |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5571840A (fr) |
| EP (1) | EP0751769B1 (fr) |
| JP (1) | JPH09503485A (fr) |
| KR (1) | KR100348117B1 (fr) |
| AT (1) | ATE230986T1 (fr) |
| AU (1) | AU680669B2 (fr) |
| CA (1) | CA2165822A1 (fr) |
| DE (1) | DE69432027T2 (fr) |
| DK (1) | DK0751769T3 (fr) |
| ES (1) | ES2192194T3 (fr) |
| WO (1) | WO1995000135A1 (fr) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9401891D0 (en) | 1994-02-01 | 1994-03-30 | Boots Co Plc | Therapeutic agents |
| WO2000047434A1 (fr) | 1999-02-10 | 2000-08-17 | Erik Zapletal | Systeme de suspension equilibree |
| AU4799700A (en) | 1999-04-27 | 2000-11-10 | Board Of Regents, The University Of Texas System | A composition and method for treatment of cerebral ischemia |
| AU778522B2 (en) | 1999-10-29 | 2004-12-09 | Orion Corporation | Treatment or prevention of hypotension and shock |
| US7235649B2 (en) * | 2000-03-24 | 2007-06-26 | Duke University | Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same |
| WO2001072779A1 (fr) * | 2000-03-24 | 2001-10-04 | Duke University | Caracterisation d'interactions ligands-grp94 et methodes de purification, de criblage et de traitement associees |
| US20020193440A1 (en) * | 2001-02-20 | 2002-12-19 | Ritter Steven C. | Liothyronine sodium and levothyroxine sodium combination |
| US6645526B2 (en) * | 2001-11-13 | 2003-11-11 | Mylan Pharmaceuticals, Inc. | Storage stable thyroxine active drug formulations and methods for their production |
| US20030099699A1 (en) | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
| US20040156893A1 (en) * | 2003-02-11 | 2004-08-12 | Irwin Klein | Method for treating hypothyroidism |
| ITRM20030363A1 (it) * | 2003-07-24 | 2005-01-25 | Fernando Goglia | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse. |
| US8668926B1 (en) | 2003-09-15 | 2014-03-11 | Shaker A. Mousa | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| US8071134B2 (en) | 2003-09-15 | 2011-12-06 | Ordway Research Institute, Inc. | Thyroid hormone analogs and methods of use |
| AU2004273986B2 (en) * | 2003-09-15 | 2010-04-22 | Nanopharmaceuticals Llc | Thyroid hormone analogs and methods of use in angiogenesis |
| US9198887B2 (en) | 2003-09-15 | 2015-12-01 | Nanopharmaceuticals Llc | Thyroid hormone analogs and methods of use |
| WO2005051298A2 (fr) * | 2003-11-19 | 2005-06-09 | Metabasis Therapeutics, Inc. | Nouvelles substances thyromimetiques contenant du phosphore |
| CA2583410A1 (fr) * | 2004-09-15 | 2006-03-23 | Albany College Of Pharmacy | Analogues d'hormones thyroidiennes et procedes d'utilisation correspondants |
| US20060128797A1 (en) * | 2004-12-15 | 2006-06-15 | Yanming Wang | Method and composition for resuscitation |
| AU2006230557A1 (en) * | 2005-03-31 | 2006-10-05 | King Pharmaceuticals Research & Development, Inc. | Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same |
| JP2008545711A (ja) * | 2005-05-26 | 2008-12-18 | メタバシス・セラピューティクス・インコーポレイテッド | 新規ホスフィン酸含有甲状腺ホルモン様剤 |
| US20090232879A1 (en) | 2005-05-26 | 2009-09-17 | Metabasis Therapeutics, Inc. | Thyromimetics for the Treatment of Fatty Liver Diseases |
| US9498536B2 (en) | 2005-09-15 | 2016-11-22 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders |
| US10130686B2 (en) | 2005-09-15 | 2018-11-20 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders |
| US20100209382A1 (en) | 2005-09-16 | 2010-08-19 | Ordway Research Institute, Inc. | Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use |
| WO2008140507A2 (fr) | 2006-12-22 | 2008-11-20 | Clf Medical Technology Acceleration Program, Inc. | Formulations de nanoparticules et de polymères pour les analogues, les antagonistes et les formulations de l'hormone thyroïde et leurs utilisations |
| US9180107B2 (en) | 2009-03-31 | 2015-11-10 | Nanopharmaceuticals Llc | Combination treatment of cancer with cetuximab and tetrac |
| CA2762107A1 (fr) * | 2009-05-15 | 2010-11-18 | Recro Pharma, Inc. | Compositions sublinguales de dexmedetomidine et leurs procedes d'utilisation |
| EP2442800B1 (fr) | 2009-06-17 | 2019-04-24 | NanoPharmaceuticals LLC | Formulations nanoparticulaires et de polymères pour hormone thyroïdienne, analogues, antagonistes et formulations et utilisations de celles-ci |
| US8802240B2 (en) | 2011-01-06 | 2014-08-12 | Nanopharmaceuticals Llc | Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| EP2787970B1 (fr) | 2011-12-11 | 2018-04-11 | Recro Pharma, Inc. | Compositions intranasales de dexmédétomidine et leurs procédés d'utilisation |
| US10060934B2 (en) | 2013-11-18 | 2018-08-28 | Nanopharmaceuticals Llc | Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof |
| WO2017003125A1 (fr) * | 2015-06-29 | 2017-01-05 | 한양대학교 산학협력단 | Composition contenant de la triiodidethyronine, de la tyroxine, ou leur sel, pour prévenir, soulager, ou traiter des maladies des nerfs crâniens |
| WO2017214299A1 (fr) | 2016-06-07 | 2017-12-14 | Nanopharmaceuticals, Llc | Polymère non clivable conjugué avec des antagonistes thyroïdiens de l'intégrine αvβ3 |
| KR20190104524A (ko) | 2016-11-21 | 2019-09-10 | 바이킹 테라퓨틱스 인코포레이티드 | 당원축적질환의 치료 방법 |
| EP3634426A4 (fr) | 2017-06-05 | 2021-04-07 | Viking Therapeutics, Inc. | Compositions pour le traitement d'une fibrose |
| WO2018226991A1 (fr) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Dispositifs de déplacement de fluide intravasculaire, systèmes et procédés d'utilisation |
| CN111556763B (zh) | 2017-11-13 | 2023-09-01 | 施菲姆德控股有限责任公司 | 血管内流体运动装置、系统 |
| EP4085965A1 (fr) | 2018-02-01 | 2022-11-09 | Shifamed Holdings, LLC | Pompes à sang intravasculaires et procédés d'utilisation et de fabrication |
| EA202091979A1 (ru) | 2018-03-22 | 2021-06-22 | Вайкинг Терапьютикс, Инк. | Кристаллические формы и способы получения кристаллических форм соединения |
| US10328043B1 (en) | 2018-04-11 | 2019-06-25 | Nanopharmaceuticals, Llc. | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US11351137B2 (en) | 2018-04-11 | 2022-06-07 | Nanopharmaceuticals Llc | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US12102646B2 (en) | 2018-12-05 | 2024-10-01 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis and inflammation |
| EP3908272B1 (fr) * | 2019-01-09 | 2023-03-22 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | L-triiodothyronine (t3) pour limitation dans l'obstruction microvasculaire |
| JP2022540616A (ja) | 2019-07-12 | 2022-09-16 | シファメド・ホールディングス・エルエルシー | 血管内血液ポンプならびに製造および使用の方法 |
| US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
| WO2021062270A1 (fr) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Pompes à sang de cathéter et boîtiers de pompe pliables |
| GR1010068B (el) * | 2020-04-21 | 2021-09-01 | UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE" | Φαρμακευτικη συνθεση που περιεχει l-τριιωδοθυρονινη (τ3) για χρηση στη θεραπεια ασθενων σε κρισιμη κατασταση με λοιμωξη απο κορωνοϊο |
| US10961204B1 (en) | 2020-04-29 | 2021-03-30 | Nanopharmaceuticals Llc | Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors |
| US11723888B2 (en) | 2021-12-09 | 2023-08-15 | Nanopharmaceuticals Llc | Polymer conjugated thyrointegrin antagonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1237435B (it) * | 1989-12-14 | 1993-06-04 | Farmaco attivo nel ripristino della plasticita' neuronale. | |
| WO1991011181A1 (fr) * | 1990-02-05 | 1991-08-08 | British Technology Group (Usa) Incorporated | Traitement cardiaque par hormones thyroidiennes |
| US5158978A (en) * | 1990-02-05 | 1992-10-27 | British Technology Group (U.S.A.) | Thyroid hormone treatment of acute cardiovascular compromise |
-
1994
- 1994-06-06 US US08/254,417 patent/US5571840A/en not_active Expired - Fee Related
- 1994-06-22 EP EP94921305A patent/EP0751769B1/fr not_active Expired - Lifetime
- 1994-06-22 CA CA002165822A patent/CA2165822A1/fr not_active Abandoned
- 1994-06-22 AT AT94921305T patent/ATE230986T1/de not_active IP Right Cessation
- 1994-06-22 ES ES94921305T patent/ES2192194T3/es not_active Expired - Lifetime
- 1994-06-22 AU AU72080/94A patent/AU680669B2/en not_active Ceased
- 1994-06-22 WO PCT/US1994/006772 patent/WO1995000135A1/fr active IP Right Grant
- 1994-06-22 DK DK94921305T patent/DK0751769T3/da active
- 1994-06-22 JP JP7502930A patent/JPH09503485A/ja not_active Ceased
- 1994-06-22 DE DE69432027T patent/DE69432027T2/de not_active Expired - Fee Related
- 1994-06-22 KR KR1019950705857A patent/KR100348117B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0751769A1 (fr) | 1997-01-08 |
| DE69432027T2 (de) | 2003-10-09 |
| DE69432027D1 (de) | 2003-02-20 |
| US5571840A (en) | 1996-11-05 |
| EP0751769B1 (fr) | 2003-01-15 |
| KR100348117B1 (ko) | 2002-12-02 |
| AU7208094A (en) | 1995-01-17 |
| AU680669B2 (en) | 1997-08-07 |
| EP0751769A4 (fr) | 1998-05-27 |
| ATE230986T1 (de) | 2003-02-15 |
| CA2165822A1 (fr) | 1995-01-05 |
| JPH09503485A (ja) | 1997-04-08 |
| WO1995000135A1 (fr) | 1995-01-05 |
| ES2192194T3 (es) | 2003-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0751769T3 (da) | Medicinsk behandling under anvendelse af skjoldbruskhormoner | |
| ES2191068T3 (es) | Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel. | |
| ES2115638T3 (es) | Composicion tiroactiva de liberacion controlada. | |
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| ES2084390T3 (es) | Comprimidos de liberacion controlada, de varias capas, que contienen tanto naproxen como sal sodica de naproxen. | |
| PT741577E (pt) | Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado | |
| DK0814796T3 (da) | Anvendelse af et R-NSAID i en protektiv sammensætning til behandling af kolorektal cancer | |
| DE3752112D1 (de) | Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen | |
| DK581685D0 (da) | Transderimalt system for timolol-indgift | |
| ATE78169T1 (de) | Behandlung von diabetes durch kombinierte insulinformen. | |
| NO305581B1 (no) | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose | |
| KR950702120A (ko) | 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis) | |
| MY104521A (en) | Treatment of depression. | |
| DK0590355T3 (da) | Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter | |
| DE69028971D1 (de) | Hypertensiver faktor des parathyroids | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| MX9201288A (es) | Metodo de tratamiento. | |
| ATE8966T1 (de) | Analgetische potenzierung. | |
| ES8500055A1 (es) | Procedimiento para la obtencion de un medicamento a base de un derivado de pirazolinona. | |
| IL107818A0 (en) | Method of treating viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vinyl substituted nucleoside analog | |
| SG49645A1 (en) | A method of treating liver disease and like indications with vasodilating agents | |
| Ellison et al. | Penetration of I super (125) labelled N. nigricollis venom in relationship to effects on the corneal erosion syndrome in albino and pigmented rabbits. | |
| UA10995C2 (uk) | Препарат "hейтрам" для лікуваhhя hеоhатальhих діарей у телят | |
| JPS5553218A (en) | Medical application of dilute aqueous solution of sodium hydroxide | |
| MX9706404A (es) | Metodo para tratar deplecion de adenosina. |